Aqua Bio Technology ASA (OSL:ABTEC)

Market Cap	106.39M +50.4%
Revenue (ttm)	101.51M +293.3%
Net Income	-144.70M
EPS	-66.24
Shares Out	15.19M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	6,431
Open	n/a
Previous Close	7.01
Day's Range	n/a
52-Week Range	4.60 - 123.00
Beta	0.31
RSI	47.56
Earnings Date	Apr 28, 2026

About Aqua Bio Technology ASA

Aqua Bio Technology ASA engages in the manufacture and sale of ingredients for cosmetic industry in Norway. The company offers Aquabeautine XL, a proprietary ingredient for skincare products; and Spirulysat, an antioxidant and vitamin-boosted spirulina for cosmetic use. The company distributes its products through internet, stores, and skincare clinics. Aqua Bio Technology ASA was founded in 2000 and is based in Oslo, Norway.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2000
• Employees: 37
• Stock Exchange: Oslo Børs
• Ticker Symbol: ABTEC

Financial Performance

In 2024, Aqua Bio Technology ASA's revenue was 107.17 million, an increase of 472.00% compared to the previous year's 18.74 million. Losses were -337.35 million, 1504.6% more than in 2023.